South and Central America Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Vaccine Type and Route of administration and Country

According to a new market research study of “South and Central America Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Analysis by Vaccine Type and Route Of Administration, South and Central America typhoid fever vaccines market is projected to reach US$ US$ 24.37 million in 2027 from US$ 13.79 million. The market is estimated to grow at CAGR of 7.7% from 2020 to 2027. The report highlights trends prevailing in the South and Central America typhoid fever vaccines market and the factors driving market along with those that act as hindrances.

The typhoid fever vaccines market, based on vaccine type, is further segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR in the market during the forecast period. Polysaccharide (PS) vaccines are antibacterial vaccines with unique characteristics and their main advantage is the simplicity of production and high effectiveness against the bacteria.

South and Central America typhoid fever vaccines market is expected to grow owing to the key prevalence of typhoid in the region, and poor sanitation facilities. However, risks associated with typhoid fever vaccines is likely to have a negative impact on the growth of the market in the coming years.

Leading companies operating in the South and Central America typhoid fever vaccines market are GlaxoSmithKline plc, Shanghai institute of biological products co., ltd., Sanofi, Pax Vax Inc, BHARAT BIOTECH among others.

The report segments South and Central America Typhoid Fever Vaccines market as follows:

By Vaccine Type

• Live Attenuated Vaccine
• Capsular Polysaccharide Vaccines
• Conjugate Vaccine
• Others

By Route of Administration

• Oral
• Injectable

By Country

• Brazil
• Argentina
• Rest of South and Central America

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America typhoid fever vaccines market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the South and Central America typhoid fever vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.